![Temi Oduozor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Temi Oduozor
Keine laufenden Positionen mehr
Karriereverlauf von Temi Oduozor
Ehemalige bekannte Positionen von Temi Oduozor
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GIGA-TRONICS INCORPORATED | Comptroller/Controller/Auditor | 07.08.2016 | 23.02.2018 |
Finanzdirektor/CFO | - | 23.02.2018 | |
ANTHERA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.07.2011 | 01.11.2014 |
QUESTCOR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.01.2008 | 01.01.2011 |
Ausbildung von Temi Oduozor
The California State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Comptroller/Controller/Auditor | 3 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Electronic Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GIGA-TRONICS INCORPORATED | Electronic Technology |
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Questcor Pharmaceuticals, Inc.
![]() Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
- Börse
- Insiders
- Temi Oduozor
- Erfahrung